When examining the compatibility with Union law of the conditions for the retail supply of medicinal products, the Court of Justice of the European Union (‘the Court of Justice’) has recognised the very particular nature of medicinal products, whose therapeutic effects distinguish them substantially from other goods. The Court of Justice has also held that health and life of humans rank foremost among the assets and interests protected by the TFEU and that it is for Member States to determine the level of protection which they wish to afford to public health and the way in which that level has to be achieved. Since that level may vary from one Member State to another, Member States must be allowed discretion [Judgment of the Court of 19 May 2009 in Joined Cases C-171/07 and C-172/07 Apothekerkammer des Saarlandes and Others v Saarland ECR [2009] I-4171, paragraphs 19 and 31.] as regards the conditions for the supply on their territory of medicinal products to the public.
Recital 22, Directive (EU) 2011/62
Judgment of the Court (Second Chamber) of 29 February 2024. Doctipharma SAS v Union des Groupements de pharmaciens d’officine (UDGPO) and PiDecision
Recitals 21 to 24 of Directive 2011/62 are worded as follows: The illegal sale of medicinal products to the public via the Internet is an important threat to public health as falsified medicinal products may reach the public in this way. …
29 Feb 2024 · 62021CJ0606
Opinion of Advocate General Szpunar delivered on 13 July 2023. Doctipharma SAS v Union des Groupements de pharmaciens d’officine (UDGPO) andDecision
In view of the general nature of the terms used in those two provisions, and in particular the wording used in Article 85c(2) of Directive 2001/83 (‘[conditions] for the retail supply … of medicinal products for sale at a distance to …
13 Jul 2023 · 62021CC0606
Opinion of Advocate General Saugmandsgaard Øe delivered on 27 February 2020. A v Daniel B and Others.Decision
In the context of that proportionality assessment, account must be taken of the fact that the health and life of humans rank, according to the settled case-law, foremost among the assets and interests protected by the FEU Treaty. It is for …
27 Feb 2020 · 62018CC0649
Opinion of Advocate General Szpunar delivered on 18 December 2025. FARMAKEIO YZ & SIA O.E. v Ypourgos Anaptyxis kai Ependyseon and Ypourgos Decision
That interpretation is corroborated by recitals 21 to 24 of Directive 2011/62, which concern the matters covered by Article 85c(2) of Directive 2001/83.
18 Dec 2025 · 62024CC0604
Opinion of Advocate General Szpunar delivered on 20 May 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és Decision
As is clear from the judgment in Apothekerkammer des Saarlandes and Others, [Judgment of 19 May 2009 (C‑171/07 and C‑172/07, EU:C:2009:316).] to which recitals 22 and 23 of Directive 2011/62 refer, and from the judgment in VIPA, …
20 May 2021 · 62020CC0178
Judgment of the Court (Fifth Chamber) of 21 May 2026. FARMAKEIO YZ & SIA O.E. v Ypourgos Anaptyxis kai Ependyseon and Ypourgos Ygeias.Decision
Recitals 21 to 24 of Directive 2011/62 state: The illegal sale of medicinal products to the public via the Internet is an important threat to public health as falsified medicinal products may reach the public in this way. It is necessary …
21 May 2026 · 62024CJ0604
Judgment of the Court (Grand Chamber) of 19 May 2009. Apothekerkammer des Saarlandes and Others (C-171/07) and Helga Neumann-Seiwert (C-172/Decision
19 May 2009 · 62007CJ0171